Prophylactic anti-coagulation in cancer palliative care: a prospective randomised study
- 326 Downloads
The objective of this study was to determine utility of prophylactic anti-coagulation in cancer patients hospitalised for palliative care in a specialised centre.
Materials and methods
Prospective 1:1 open randomised study was designed. Twenty patients aged 55 to 88 years with advanced cancer and an estimated life expectancy of less than 6 months were assigned to either receive treatment with 2,850/3,800 U (<70/>70 kg) of daily subcutaneous nadroparin or no treatment. Suspicion of venous thrombo-embolism (deep vein thrombosis and pulmonary embolism) was confirmed by echo-Doppler examination of the lower limbs and/or by spiral computed tomography scan of the lungs. Bleeding episodes were recorded. Platelet count was measured on days 7 and 14. Survival time from study entry was determined.
One venous thrombo-embolism and one major bleeding occurred in the group receiving nadroparin, whereas two minor bleedings occurred in the control group. At 3 months, nine of ten participants had died in the control group vs five of ten in the group receiving nadroparin (P = 0.141). Five participants could be discharged home (P = 0.141).
Decision to administer prophylactic nadroparin in hospitalised cancer patients under palliative care remains a challenge. Better mobility score at admission and the likelihood to be discharged home may be useful for practical purposes. The observation of a potential influence of prophylactic nadroparin on survival deserves further studies.
KeywordsAnti-coagulation Cancer Palliative care Thrombosis Bleeding
- 3.Bruera E, Neumann CM (1998) Management of specific symptom complexes in patients receiving palliative care. Can Med Assoc J 158:1717–1726Google Scholar
- 7.Federal Office of Statistics (Switzerland). http://www.bfs.admin.ch/
- 10.Gouin-Thibaut I, Samama MM (2000) Venous thrombosis and cancer. Ann Biol Clin (Paris) 58:675–682Google Scholar
- 22.Merminod T, Zulian GB (2007) Venous thromboembolism in cancer patients under palliative care: retrospective study with lessons to the future. Supportive Palliative Cancer Care J (in press)Google Scholar
- 23.Pautex S, Moynier K, Weber C, Zulian GB (2002) L’évaluation des symptômes en oncologie palliative. Méd Hyg 60:1313–1317Google Scholar
- 26.Trousseau A (1865) Phlegmasia Alba Dolens. Clinique médicale de l’Hôtel Dieu de Paris, vol 3. The New Sydenham Society, London, p 94Google Scholar
- 28.World Heath Organization. http://www.who.int/cancer/palliative/definition/en/